Home
About
FAQ
History (2)
From xenon to argon: a more clinically accessible neuroprotectant?
Imaging surveillance for cardiovascular complications of cancer therapy.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
From xenon to argon: a more clinically accessible neuroprotectant?
Ezzeddine MA. From xenon to argon: a more clinically accessible neuroprotectant? Crit Care Med. 2011 Jun; 39(6):1589-90.
View in:
PubMed
subject areas
Animals
Argon
Humans
Infarction, Middle Cerebral Artery
Neuroprotective Agents
Xenon
authors with profiles
Mustapha A. Ezzeddine MD